Welcome to Chimerix

Chimerix, Inc.

Chimerix discovers, develops and commercializes therapeutics with enhanced pharmaceutical properties that are active against a broad range of viral diseases. Leveraging a powerful lipid prodrug technology, ProLipTagTM, Chimerix is able to develop drug candidates with oral-availability, increased potency and targeted delivery. These enhanced pharmaceutical properties can be applied to new drug moieties or known drugs to improve dosing parameters, broaden therapeutic applications and decrease the risk of adverse reactions.

Technology Benefits

Leveraging a powerful lipid, pro-drug technology Chimerix is able to develop drug candidates with improved oral-availability. [more]

Product Pipeline

Product pipeline developed based on the Chimerix technology ProLipTagTM [more]

Latest News

April 1, 2008

Potential wonder drugs - Chimerix article in The New Economy

[more]

January 29, 2008

Merial to Screen Chimerix’ Chemical Library for Animal Health Drug Leads

[more]

read all news

Next Event

April 14, 2008 - Chimerix to present at ICAR 2008

Development of hexadecyl-oxypropyl cidofovir (CMX001) for double stranded DNA (dsDNA) virus infections

[more]

April 18, 2008 - Chimerix to present at 25th Annual Venture Conference

Chimerix company overview

[more]